Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
Cancer-Related Pain and Sexual Orientation and Gender Identity: An Intersectional Approach.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boehmer Ulrike, Wesselmann Ursula, Jesdale Bill M
Аннотация
BACKGROUND: We examined cancer-related pain in sexual and gender minorities (SGM) compared with heterosexual cisgender populations and evaluated sociodemographic factors within SGM and heterosexual cisgender cancer survivors.
METHODS: We combined 2014 to 2023 data of the Behavioral Risk Factor Surveillance System from 23 states and Guam that administered the sexual orientation and gender identity module and the pain-specific cancer survivorship module. Our analytic sample consisted of 56,217 cancer survivors, 1,655 of whom identified as SGM.
RESULTS: Sexual minority cancer survivors reported twice or more the prevalence of cancer pain than heterosexual cisgender survivors, with gender minority cancer survivors reporting cancer pain most frequently (28%), followed by sexual minority women (17%), and sexual minority men (14%). Sociodemographic subgroups, consisting of younger, unmarried, not employed, and those with low income, are at increased risk of experiencing cancer pain.
CONCLUSIONS: Our findings point to heterogeneity among sexual minority cancer survivors' prevalence of pain and additional efforts to characterize gender minorities' disparities in cancer pain.
IMPACT: There is an urgent need for evidence-based real-life clinical data characterization of SGM cancer pain disparities and efforts to reduce their cancer-related pain. See related In the Spotlight, p. 1236.
METHODS: We combined 2014 to 2023 data of the Behavioral Risk Factor Surveillance System from 23 states and Guam that administered the sexual orientation and gender identity module and the pain-specific cancer survivorship module. Our analytic sample consisted of 56,217 cancer survivors, 1,655 of whom identified as SGM.
RESULTS: Sexual minority cancer survivors reported twice or more the prevalence of cancer pain than heterosexual cisgender survivors, with gender minority cancer survivors reporting cancer pain most frequently (28%), followed by sexual minority women (17%), and sexual minority men (14%). Sociodemographic subgroups, consisting of younger, unmarried, not employed, and those with low income, are at increased risk of experiencing cancer pain.
CONCLUSIONS: Our findings point to heterogeneity among sexual minority cancer survivors' prevalence of pain and additional efforts to characterize gender minorities' disparities in cancer pain.
IMPACT: There is an urgent need for evidence-based real-life clinical data characterization of SGM cancer pain disparities and efforts to reduce their cancer-related pain. See related In the Spotlight, p. 1236.